Risk Breakdown
Financial Exposure
Governance
Double Materiality
Supply Chain
Material Risks
AI Risk Summary
**Financial Risk Summary – Syncom Formulations (India) Limited** Syncom's largest financial exposure stems from critical compliance gaps: a perfect 10.0/10 compliance risk score with estimated remediation costs of ₹1–3 crore, compounded by high EPR (Extended Producer Responsibility) exposure uncertainty that could trigger unquantified liability under pharmaceutical waste management rules. Non-compliance with SEBI BRSR Core Expansion disclosure mandates exposes the company to enforcement action and potential delisting risk, particularly material given its ₹462.8 crore revenue base. The absence of reported Scope 1 and 2 emissions data—despite operating a manufacturing facility—suggests incomplete GHG accounting rather than genuine zero emissions, representing a regulatory red flag under BRSR P6 environmental disclosures that could trigger scrutiny and reputational costs. Immediate priority: establish baseline emissions inventory, clarify EPR applicability and associated contingent liabilities, and implement BRSR disclosure compliance infrastructure to mitigate regulatory and market access risks.
Source: Syncom Formulations (India) Limited BRSR Filing, FY -. Derived from the company's own public disclosures. Not investment advice or a regulatory determination.